1 New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Oct 30, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
Read More Disease Uremia Is Most Likely To Be "Dragged Out", The Body Appears 3 "Abnormal", Check As Soon As Possible Nov 11, 2024
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Apparatus Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer! Nov 22, 2024
Read More Medical Two In a Row From Science: Car-T Cells Are Back With a New Upgrade That May Eradicate Deadly Solid Tumours! Nov 18, 2024
